The global epilepsy drugs market was valued at USD 10 billion in 2022 and grew at a CAGR of 4% from 2023 to 2032. The market is expected to reach USD 14.80 billion by 2032. The increasing prevalence of epilepsy will drive the growth of the global epilepsy drugs market.
Epilepsy drugs are also known as antiepileptic drugs (AEDs). They play a crucial role in managing epilepsy by controlling and preventing seizures. These medications target various mechanisms within the brain to modulate abnormal electrical activity. Phenytoin and carbamazepine, valproic acid and clonazepam, ethosuximide, and levetiracetam are a few examples of epilepsy drugs. Epilepsy drugs stabilize electrical activity in the brain by reducing the frequency and intensity of seizures. The benefits of these medications extend beyond seizure control, encompassing an improved quality of life for individuals with epilepsy. Epilepsy drugs also contribute to psychosocial well-being. Additionally, these drugs play a vital role in preventing complications associated with uncontrolled epilepsy, such as injuries and accidents. The selection of specific drugs is personalized based on the type of seizures and individual patient characteristics.
Get an overview of this study by requesting a free sample
The increasing prevalence of epilepsy due to accidents and injuries – The increased occurrences of accidents, sports injuries, and other trauma-related violence have contributed to an increasing incidence of epilepsy. Additionally, increases in infectious diseases, particularly those affecting the central nervous system (CNS), pose another potential risk factor for epilepsy. Outbreaks of CNS infections, like encephalitis or meningitis, can result in inflammation and scarring in the brain, contributing to an elevated risk of developing epilepsy. The rising incidence of infectious diseases on a global scale and increasing incidence of accidents will increase the risk of epilepsy and drive the global epilepsy drugs market’s growth.
The side effects associated with epilepsy drugs – Cognitive effects such as memory issues, gastrointestinal distress, dizziness, and mood changes are common side effects of epilepsy drugs. Skin reactions and weight changes are also possible. These side effects can impact daily functioning and quality of life, potentially leading to discontinuation of treatment by many. Therefore, the side effects of epilepsy drugs may limit its adoption, thereby limiting the market's growth.
Increasing research and development infrastructure – the development and approval of new antiepileptic drugs (AEDs) mark the advancements in epilepsy drugs in the recent past. These innovations enhance treatment outcomes by improving efficacy, minimizing side effects, and expanding therapeutic options. These advancements reflect positive strides in epilepsy drug development and will contribute to the global epilepsy drug market's growth and development in the future.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global epilepsy drugs market, with a 36% market revenue share in 2022.
The North American epilepsy drugs market thrives due to its advanced research and development landscape. It is also home to prominent pharmaceutical companies and research institutions, furthering innovation and research in epilepsy drugs. The robust regulatory environment improves compliance, efficacy and accountability of drugs. High healthcare spending contributes to the market's growth.
North America Region Epilepsy Drugs Market Share in 2022 - 36%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The drug class segment is divided into first-generation drugs, second-generation drugs, and third-generation drugs. The second-generation drugs segment dominated the market, with a market share of around 44% in 2022. Second-generation epilepsy drugs include Lamotrigine, Levetiracetam, and Topiramate. They offer greater benefits than their older counterparts. Their broader spectrum of activity makes them effective against various seizure types and epilepsy syndromes. These drugs generally present improved side effect profiles with fewer cognitive effects. Convenience in dosing, Reduced drug interactions and a lower likelihood of side effects contribute to their popularity. These drugs provide flexibility and improved tolerability in epilepsy management.
The distribution channel segment is divided into hospital pharmacies, retail pharmacies and online pharmacies. The retail pharmacies segment dominated the market, with a market share of around 45% in 2022. Pharmacies are preferred venues for obtaining epilepsy drugs due to their widespread accessibility and convenience. As trained healthcare professionals, pharmacists provide essential expertise, offering guidance on proper medication usage, potential side effects, and interactions. Additionally, pharmacies maintain adequate stocks of commonly prescribed epilepsy drugs, ensuring availability at all times.
Report Description:
Attribute | Description |
---|---|
Market Size | Revenue (USD Billion) |
Market size value in 2022 | USD 10 Billion |
Market size value in 2032 | USD 14.80 Billion |
CAGR (2023 to 2032) | 4% |
Historical data | 2019-2021 |
Base Year | 2022 |
Forecast | 2023-2032 |
Region | The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East and Africa. Furthermore, the regions are further analyzed at the country level. |
Segments | Drug Class and Distribution Channel |
As per The Brainy Insights, the size of the global epilepsy drugs market was valued at USD 10 billion in 2022 to USD 14.80 billion by 2032.
Global epilepsy drugs market is growing at a CAGR of 4% during the forecast period 2023-2032.
The market's growth will be influenced by the increasing prevalence of epilepsy due to accidents and injuries.
The side effects associated with epilepsy drugs could hamper the market growth.
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global epilepsy drugs market based on below mentioned segments:
Global Epilepsy Drugs Market by Drug Class:
Global Epilepsy Drugs Market by Distribution Channel:
Global Epilepsy Drugs Market by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date